-
Interplay between molecular and environmental factors in the new era of precision medicine
Jordi Merino Ribas University of Copenhagen, Denmark 13:00~13:20 -
Human microbiome and the path to cardiometabolic health
Hyun Ju You Seoul National University, Republic of Korea 13:20~13:40 -
Nutritional regulation of iron metabolism in cardiometabolic diseases
Hyekyoung Sung York University, Canada 13:40~14:00 - Panel Discussion 14:00~14:30
-
From nanoparticles to biocides: how toxic chemicals alter lipid homeostasis and accelerate atherosclerotic events
Ok-Nam Bae Hanyang University, Republic of Korea 13:00~13:20 -
Immune modulation of lipid metabolism promotes BAT whitening under thermoneutral conditions
Jun Young Hong Yonsei University, Republic of Korea 13:20~13:40 -
Roles of MCU in human platelets on platelet aggregation
Jin O-Uchi University of South Florida, USA 13:40~14:00 - Panel Discussion 14:00~14:30
-
Coronary atherosclerosis and cardiovascular risk prediction through AI-assisted stress echocardiography: insights from the PROTEUS RCT trial
Paul Leeson University of Oxford, UK 14:40~15:00 -
AI-enhanced ECG for acute myocardial infarction detection and cardiovascular risk stratification
Junmyung Kwon Medical AI, Republic of Korea 15:00~15:20 -
Large language model based cardiovascular risk prediction enhancing clinical decision making
SungA Bae Yonsei University, Republic of Korea 15:20~15:40 - Panel Discussion 15:40~16:10
-
CVD risk prediction in low-risk population
Hokyou Lee Yonsei University, Republic of Korea 14:40~15:00 -
CVD risk prediction in older persons
Sangwoo Park University Of Ulsan, Republic of Korea 15:00~15:20 -
CVD risk prediction in diabetes and high-risk patients
Eu Jeong Ku Seoul National University, Republic of Korea 15:20~15:40 - Panel Discussion 15:40~16:10
-
Deep dive into PCSK9: the master regulator of LDL metabolism and inflammation
Hyun Duk Jang Seoul National University, Republic of Korea 14:40~15:00 -
siRNA-based lipid therapies: a revolution in cholesterol management
Jin Wi Gachon University, Republic of Korea 15:00~15:20 -
Novel strategies for familial hypercholesterolemia management beyond statins
Rodrigo Alonso Center for Advanced Metabolic Medicine and Nutrition, Chile 15:20~15:40 - Panel Discussion 15:40~16:10
-
Prediction of ASCVD using the TyG index: insights from the multinational PURE registry
Patricio Lopez-Jaramillo Universidad de Santander, Colombia 16:20~16:40 -
Prediction of ASCVD using the TyG index: evidence from Korean data
Yong-Jae Lee Yonsei University, Republic of Korea 16:40~17:00 -
Prediction of coronary artery calcification progression using the TyG index
Ki-Bum Won Chung-Ang University, Republic of Korea 17:00~17:20 - Panel Discussion 17:20~17:50
-
Beyond statins: advances in FH management
Chan Joo Lee Yonsei University, Republic of Korea 16:20~16:40 -
Early detection of FH: role of genetic screening and cascade testing
Hayato Tada Kanazawa University, Japan 16:40~17:00 -
Cardiovascular risk in FH: how early is early enough for intervention?
Po-Sheng Chen National Cheng Kung University, Taiwan 17:00~17:20 - Panel Discussion 17:20~17:50
-
LDL-C targets for patients with diabetes across major guidelines
Jong Han Choi Konkuk University, Republic of Korea 16:20~16:40 -
Pro: all patients with diabetes should be treated to LDL-C <55 mg/dL?
Wonjin Kim CHA University, Republic of Korea 16:40~17:00 -
Cons: LDL-C targets should be personalized in diabetic patients?
Mihye Seo Soonchunhyang University, Republic of Korea 17:00~17:20 - Panel Discussion 17:20~17:50
-
Mechanisms linking socioeconomic status and cardiovascular risk
Sung Hee Choi Seoul National University, Republic of Korea 16:20~16:40 -
Epidemiological evidence on socioeconomic status and cardiovascular outcomes
Jong Ha Baek Gyeongsang National University, Republic of Korea 16:40~17:00 -
New models for CVD risk assessment: incorporating socioeconomic data
Sadiya S. Khan Northwestern University, USA 17:00~17:20 - Panel Discussion 17:20~17:50
-
Exploring the genetic landscape of CVD and diabetes: finding and future implication
Soo Heon Kwak Seoul National University, Republic of Korea 08:30~08:50 -
Multi-omics and multi-trait analysis of metabolic disease
Hong Hee Won Sungkyunkwan University, Republic of Korea 08:50~09:10 -
Recent progress in gene-targeting therapy for familial hypercholesterolemia
Sang Hak Lee Yonsei University, Republic of Korea 09:10~09:30 - Panel Discussion 09:30~10:00
-
Inflammation and atherosclerosis: emerging biomarkers and anti-inflammatory therapies
TBD 08:30~08:50 -
The role of digital health technology in managing atherosclerosis: a new frontier
Hun Sung Kim The Catholic University of Korea, Republic of Korea 08:50~09:10 -
Impact of lipid-lowering therapy on aortic aneurysm progression and cardiovascular outcomes
Gyu Chul Oh The Catholic University of Korea, Republic of Korea 09:10~09:30 - Panel Discussion 09:30~10:00
-
Remnant cholesterol as a residual risk in ASCVD patients under statin-based lipid-lowering therapy
Sung Gyun Ahn Yonsei University, Republic of Korea 08:30~08:50 -
Association between remnant cholesterol and sarcopenia: implications on muscle health
Soo Yeon Jang Korea University, Republic of Korea 08:50~09:10 -
Targeting remnant cholesterol in the era of precision lipid management
Pablo Corral Fasta University, Argentina 09:10~09:30 - Panel Discussion 09:30~10:00
-
Vascular tortuocity and atherosclerosis burden
Mi-Yeon Eun Kyungpook National University, Republic of Korea 13:00~13:20 -
Vessel wall enhancement and inflammation
Dong-Wan Kang Seoul National University, Republic of Korea 13:20~13:40 -
Blood viscocity and intracranial atherosclerosis
Ho Geol Woo Kyung Hee University, Republic of Korea 13:40~14:00 - Panel Discussion 14:00~14:30
-
Environmental pollution as a nontraditional risk factor for atherosclerotic cardiovascular disease: mechanisms and impacts
Sun-Young Kim National Cancer Center, Republic of Korea 13:00~13:20 -
Health inequity as a nontraditional risk factor for ASCVD
Eunji Kim Gachon University, Republic of Korea 13:20~13:40 -
Psychiatric disorders: an overlooked nontraditional risk factor in the development of atherosclerotic cardiovascular disease
Seung Jin Han Ajou University, Republic of Korea 13:40~14:00 - Panel Discussion 14:00~14:30
-
Optimal LDL-C goals for secondary prevention in high-risk patients - a cardiologist’s perspective
Hyun Sung Joh Seoul National University, Republic of Korea 13:00~13:20 -
Optimal LDL-C level for stroke prevention - insights from a neurologist’s perspective
Wookjin Yang University of Ulsan, Republic of Korea 13:20~13:40 -
Different LDL-C targets by duration of diabetes: what is the evidence? - an endocrinologist’s perspective
Young-Sang Lyu Chosun University, Republic of Korea 13:40~14:00 - Panel Discussion 14:00~14:30
-
Bempedoic acid in real world practice, for whom?
Ioanna Gouni-Berthold University of Cologne, Germany 16:45~17:05 -
Targeting APOC 3 for triglyceride management
Jin Wi Gachon University, Republic of Korea 17:05~17:25 -
ANGPTL3 and ANGPTL8 inhibition: novel strategies to combat atherogenic dyslipidemia
Jang Hoon Lee Kyungpook National University, Republic of Korea 17:25~17:45 - Panel Discussion 17:45~18:15
-
Triglyceride and HDL-C focus in Asian populations: rethinking priorities?
Jaehoon Chung Dongguk University, Republic of Korea 16:45~17:05 -
Combination lipid-lowering therapy: when statins alone are not enough
TBD 17:05~17:25 -
Ethnic differences in managing dyslipidemia: tailoring treatment strategies for Asian and Western populations
Hoang Anh Tien Hue University of Medicine and Pharmacy, Vietnam 17:25~17:45 - Panel Discussion 17:45~18:15
-
Biological and hormonal mechanisms linking sex and cardiometabolic risk
Erin D. Michos Johns Hopkins University, USA 16:45~17:05 -
Sex and gender differences in risk assessment and biomarkers for cardiovascular disease
In-Jeong Cho Ewha Womans University, Republic of Korea 17:05~17:25 -
Do women and men respond differently to cardiometabolic therapies?
Hyun Ju Yoon Chonnam National University, Republic of Korea 17:25~17:45 - Panel Discussion 17:45~18:15
-
Glutamine homeostasis: an overlooked axis in cardiometabolic inflammation
Laurent Yvan-Charvet INSERM, France 16:45~17:05 -
Myeloid metabolism in the amplification and resolution of cardiac inflammation
Edward Thorp Northwestern University, USA 17:05~17:25 -
Therapeutic promise of ANGPTL4 in cardiovascular inflammation
Yong Sook Kim Chonnam National University, Republic of Korea 17:25~17:45 - Panel Discussion 17:45~18:15
-
New approaches to treating hypertriglyceridemia in patients with renal impairment
Young-Sang Lyu Chosun University, Republic of Korea 07:50~08:02 -
Pravastatin’s effects on special populations
Jae Yoon Park Dongguk University, Republic of Korea 08:02~08:14 -
Comparative effectiveness of lercanidipine and amlodipine on MACE in hypertensive patients
Hyung Joon Joo Korea University, Republic of Korea 08:14~08:26
-
Cumulative LDL-cholesterol burden and cardiovascular risk
Warren Lee University Heath Network and University of Toronto, Canada 08:50~09:10 -
Cardiovascular risk in youth: when and how to intervene?
Aram Yang Sungkyunkwan University, Republic of Korea 09:10~09:30 -
Beyond LDL-C: role of ApoB and non-HDL cholesterol in early prevention
Jae Hyoung Park Korea University, Republic of Korea 09:30~09:50 - Panel Discussion 09:50~10:20
-
Strategies for managing hyperlipidemia in fragile elderly patients
Dong-Ho Shin Yonsei University, Republic of Korea 08:50~09:10 -
Optimizing glucose control in fragile elderly patients with cardiometabolic syndrome
Soojin Yun Kyung Hee University, Republic of Korea 09:10~09:30 -
How to deal with multimorbidity and frailty for the prevention of cardiovascular disease
Hidenori Arai National Center for Geriatrics and Gerontology, Japan 09:30~09:50 - Panel Discussion 09:50~10:20
-
Anti-obesity effects of bioactive compound from natural products: a mechanism-oriented approach focusing on cellular signaling and metabolic regulation
Choon Young Kim Yeungnam University, Republic of Korea 08:50~09:10 -
Semaglutide for obesity treatment and cardiometabolic benefits
Yun Kyung Cho University Of Ulsan, Republic of Korea 09:10~09:30 -
Tirzepatide a dual GIP GLP-1 receptor agonist in obesity and metabolic care
Sang-Ho Jo Hallym University, Republic of Korea 09:30~09:50 - Panel Discussion 09:50~10:20
-
Novel health functional products to prevent post-MI pathologic remodeling
Hun-Jun Park The Catholic University of Korea, Republic of Korea 14:50~15:10 -
Ultrasonicated lespedeza cuneata extract prevents TNF-a-induced early atherosclerosis in vitro and in vivo
Sung Keun Jung Kyungpook National University, Republic of Korea 15:10~15:30 -
Regulation of mitochondrial metabolic reprogramming during aging
Jiyun Ahn Korea Food Research Institute, Republic of Korea 15:30~15:50 - Panel Discussion 15:50~16:20
-
Atherosclerosis and lipid management in cancer survivors: balancing cardiovascular and oncologic risks
Nuri Lee Chonnam National University, Republic of Korea 14:50~15:10 -
Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk equivalent
Won Kim Seoul National University, Republic of Korea 15:10~15:30 -
Atherosclerosis in chronic inflammatory diseases: focus on rheumatoid arthritis and systemic autoimmunity
Ji-Won Kim Deagu Catholic University, Republic of Korea 15:30~15:50 - Panel Discussion 15:50~16:20
-
Managing dyslipidemia in women before and after menopause
Mina Kim Korea University, Republic of Korea 16:20~16:40 -
Managing dyslipidemia in patients with liver disease
Byung Sik Kim Hanyang University, Republic of Korea 16:40~17:00 -
HIV, chronic inflammation, and dyslipidemia
Seonghoon Choi Hallym University, Republic of Korea 17:00~17:20 - Panel Discussion 17:20~17:50
-
Remnant cholesterol as a key contributor to atherosclerotic cardiovascular disease (ASCVD): mechanisms and clinical implications
Alberto Zambon University of Padua, Italy 16:20~16:40 -
The role of remnant cholesterol in chronic kidney disease (CKD)
Soo Yeon Jang Korea University, Republic of Korea 16:40~16:55 -
Association between remnant cholesterol and dementia: potential mechanisms and clinical perspectives
Han Na Jung Hallym University, Republic of Korea 16:55~17:10 -
Remnant cholesterol in women’s cardiometabolic health
Meral Kayikcioglu Ege University, Türkiye 17:10~17:30 - Panel Discussion 17:30~17:50
-
IKKε-deficient macrophages impede cardiac repair after myocardial infarction by enhancing the macrophage-myofibroblast transition
Younggeun Ahn Chonnam National University, Republic of Korea 16:20~16:40 -
Sensing ceramides by CYSLTR2 and P2RY6 to aggravate atherosclerosis
Wei Kong Peking University, China 16:40~17:00 -
Lipidomics based understanding of human disease
Hyunbeom Lee Korea Institute of Science and Technology (KIST), Republic of Korea 17:00~17:20 - Panel Discussion 17:20~17:50
-
Recent update of coronary artery calcium scoring
Nor Ashikin Md Sari University of Malaya, Malaysia 16:20~16:40 -
The role of carotid ultrasonography for the primary prevention of cardiovascular disease
Jun Hwa Hong Eulji University, Republic of Korea 16:40~17:00 -
The usefulness of brachial-ankle PWV in the risk prediction for Asians
Hack-Lyoung Kim Seoul National University, Republic of Korea 17:00~17:20 - Panel Discussion 17:20~17:50